European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

20 EU fundings (€681,640): Collaboration for Prevention and Treatment of MDR Bacterial Infections … BdlYear 2019 EU Research and Innovation programme "Horizon"

Text

Crossroads Bank for Enterprises (KBO) 0403.834.160

01/03/2019 EU funding (€1,199,125): Efficiently Networking European Neurodegeneration Research
01/11/2019 EU funding (€12M): EU Patient- cEntric clinicAl tRial pLatform
01/02/2019 EU funding (€14M): Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
01/04/2019 EU funding (€15.3M): Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation
01/10/2019 EU funding (€15M): Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies
01/03/2019 EU funding (€17.8M): Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts
14/08/2019 EU funding (€19M): Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials
01/11/2019 EU funding (€21M): Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases
01/01/2019 EU funding (€3,996,150): FAIRplus
01/03/2019 EU funding (€4,599,648): EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells
01/01/2019 EU funding (€4,999,757): Remote Assessment of Disease and Relapse – Alzheimer’s Disease
28/08/2019 EU funding (€40.3M): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
01/05/2019 EU funding (€5,687,984): Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs
29/07/2019 EU funding (€512,640): Long Acting Medicines for Complex Therapeutics Needed Now
01/04/2019 EU funding (€6,799,100): The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
01/05/2019 EU funding (€6,840,000): Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors
20/05/2019 EU funding (€7,992,823): A Centre of Excellence in Computational Biomedicine
01/11/2019 EU funding (€8,000,000): Collaboration for Prevention and Treatment of MDR Bacterial Infections
27/05/2019 EU funding (€8,000,000): MachinE Learning Ledger Orchestration for Drug DiscoverY
01/01/2019 EU funding (€9,000,000): Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Janssen Pharmaceutica N.V., Beerse, Belgium.

Creative Commons License The visualizations for "20 EU fundings (€681,640): Collaboration for Prevention and Treatment of MDR Bacterial Infections …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.